3P BIOTECH NORWAY AS: årsregnskap 2013 vs 2012
Another loss-making year
approved 2014-12-23; registry 2014-12-29; journal 2014 879433
Summary
What changed
Comparing Årsregnskap 2013 with 2012 for 3P BIOTECH NORWAY AS. Equity -51.0k NOK → -140.9k NOK.
On the constructive side: cash rose. Pressures included: operating result weakened; equity eroded.
Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
Operating result
-25.6k NOK
-89.9k NOK
-250.7%
Net result
n/m
-89.9k NOK
—
Equity
-51.0k NOK
-140.9k NOK
-176.2%
Cash
10.7k NOK
15.6k NOK
+45.3%
Total assets
107.0k NOK
182.8k NOK
+70.8%
What improved
-
↑
Cash rose
Bank deposits 10.7k NOK → 15.6k NOK (+45.3% YoY). Calculated
What deteriorated
-
↓
Operating result weakened
Operating result -25.6k NOK → -89.9k NOK. Calculated
-
↓
Equity eroded
Book equity -51.0k NOK → -140.9k NOK (equity ratio -47.7% → -77.1%). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -77.1% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation